カテゴリ： GlobalData, アメリカ, 企業調査

Boston Scientific Corp (BSX)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Boston Scientific Corp (BSX) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7310
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：192
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Boston Scientific Corp (Boston Scientific) is a medical device company that develops, manufactures and markets devices used in a range of interventional medical procedures. The company offers products in seven business groups, namely, Interventional Cardiology, Cardiac Rhythm Management (CRM), Peripheral Interventions, Electrophysiology, Endoscopy, Urology, Pelvic Health and Neuromodulation. The company markets its products to hospitals, clinics, outpatient facilities and medical offices worldwide. It has several manufacturing, distribution and technology centers worldwide. The company markets its products through direct sales organizations and a network of distributors and dealers in Europe, the Middle East, Africa, Asia-Pacific and the Americas. Boston Scientific is headquartered in Marlborough, Massachusetts, the US.

Boston Scientific Corp (BSX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 7
List of Figures 9
Boston Scientific Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 10
Boston Scientific Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 11
Boston Scientific Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 12
Boston Scientific Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 13
Boston Scientific Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 14
Boston Scientific Corp, Medical Equipment, Deal Details 22
Asset Purchase 22
Boston Scientific Acquires Tissue Processing Technology and Facility from Neovasc for USD68 Million 22
Boston Scientific Acquires Resectr Tissue Resection Device from Distal Access 23
Boston Scientific Acquires LumenR Tissue Retractor System from LumenR 24
Boston Scientific Acquires Interventional Radiology Business Of CeloNova Biosciences 25
Boston Scientific Acquires Men’s Health and Prostate Health Businesses from American Medical Systems for USD1.65 Billion 26
Boston Scientific Acquires Vascular Catheter Business of Bayer for USD414 Million 28
Boston Scientific Acquires fiXate Tissue Band From Anulex Technologies 29
Venture Financing 30
RenovoRx Raises USD7 Million in First Tranche of Venture Financing 30
Claret Medical Raises USD14.5 Million in Series C Financing 31
SetPoint Medical Raises USD30 Million in Series D Financing 32
Channel Medsystems Raises USD14.1 Million in Series C-1 Financing 34
Neuros Medical Raises USD20 Million in Series AA Financing 35
Amphora Medical Raises USD35.5 Million in Series B Financing 36
NxThera Raises Additional USD6 Million in Venture Financing 38
Claret Medical Raises USD11.2 Million Venture Financing 39
NeuroTronik Raises USD23 Million in Series B Financing 40
SetPoint Medical Raises Funds through Venture Financing 41
NxThera Raises Additional USD2.4 Million in Venture Financing 43
NxThera Raises USD12.2 Million in Venture Financing 44
Apama Medical Raises USD13 Million in Series C Financing 45
Securus Medical Raises USD10 Million in Series C Financing 46
nVision Medical Raises USD12 Million in Series B Financing 47
Apama Medical Raises USD9 Million in Venture Financing 48
nVision Medical Raises USD6.5 Million in Venture Financing 49
NxThera Raises USD40 Million Financing 50
TVA Medical Raises USD15 Million in Series C Financing 51
Setpoint Medical Raises Additional USD15 Million in Series C Venture Financing 52
Channel Medsystems Raises USD22 Million in Series C Financing Round 54
InterVene Raises USD5.9 Million in Series A Financing 55
EndoChoice Raises USD57 Million in Venture Financing 56
Apama Medical Raises USD11 Million in First Tranche of Series B Venture Financing Round 57
Claret Medical Raises up to USD18 Million in Series B Venture Financing 58
NxThera Raises Funds Through Extended Series C Financing 59
Amaranth Medical Raises Funds Through Venture Financing 60
Xlumena Raises US$25 Million In Series C Financing Round 61
Sensible Medical Raises US$20 Million In Venture Financing 62
Securus Medical Raises US$6.5 Million In Series B Financing 63
Xlumena Raises US$6 Million In Venture Financing 64
Apama Medical Raises US$3.2 Million In Series A-1 Financing Round 65
NXThera Raises US$18 Million In Series C Financing 66
Setpoint Medical Raises US$27 Million In Venture Financing 67
Claret Medical Raises US$3.6 Million In Venture Financing 68
Channel Medsystems Raises US$9.7 Million In Series B Financing 69
Baronova Raises US$27.3 Million In Series C Financing 70
EndoChoice Raises US$43 Million In Venture Financing 72
Xlumena Raises US$6 Million In Venture Financing 73
Securus Medical Group Secures USD0.25 Million in Venture Funding 74
Neuros Medical Raises US$3.5 Million In Second Round Of Financing 75
Partnerships 76
Symetis Enters Into Licensing Agreement With Endoluminal Sciences For Transcatheter Aortic Valve Implantation 76
BridgePoint Medical Enters Into Licensing Agreement With Covidien 77
Veniti Enters into Distribution Agreement with Boston Scientific 78
Boston Scientific Partners with Mayo Clinic 79
Boston Scientific Enters into Sales Cooperation Agreement with Preventice 80
Boston Scientific Enters into Agreement with Brainlab 81
Boston Scientific Enters into Distribution Agreement with C. R. Bard for Lutonix DCB 82
Boston Scientific Enters into Co-Development Agreement with Asahi Intecc 83
Boston Scientific Enters Into Distribution Agreement With Fukuda Denshi For Neuromodulation Devices 84
Boston Scientific Enters Into Agreement With Philips Healthcare 85
Vodafone Group Enters Into Co-Development Agreement With Boston Scientific For Health Monitoring System 86
Boston Scientific Extends Co-Marketing Agreement With Lumenis For Holmium Laser Fibers 87
Merger 88
EndoChoice And Peer Medical To Merge 88
Novartis Enters into Licensing Agreement with Boston Scientific for Everolimus 89
Equity Offering 90
Symetis Withdraws French Public Offering of Shares 90
Corindus Vascular Robotics Raises USD45 Million in Private Placement of Shares 91
VENITI Raises USD25 Million in Series D Equity Financing 93
MValve Technologies Raises Additional Funds through Private Placement of Shares 94
Symetis to Raise USD109.1 Million in IPO 95
Preventice Raises Funds through Private Placement of Shares 96
EndoChoice Raises USD106 Million in IPO 97
Iowa Approach Raises Funds through Private Placement of Shares 99
Debt Offering 100
Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028 100
Boston Scientific Raises USD600 Million in Public Offering of 2.850% Notes Due 2020 102
Boston Scientific Raises USD750 Million in Public Offering of 3.850% Notes Due 2025 104
Boston Scientific Raises USD500 Million in Public Offering of 3.375% Notes Due 2022 106
Boston Scientific Completes Public Offering Of Notes Due 2018 For US$600 Million 108
Boston Scientific Completes Public Offering Of Notes Due 2023 For US$450 Million 110
Asset Transactions 112
Boston Scientific Acquires Men’s Health and Prostate Health Businesses from American Medical Systems for USD1.65 Billion 112
Medifocus Completes Acquisition Of Prolieve Business From Boston Scientific For Up To USD5 Million 114
Acquisition 115
Boston Scientific to Acquire Augmenix for USD600 Million 115
Boston Scientific to Acquire VENITI 116
Boston Scientific Acquires Claret Medical for up to USD270 Million 117
Boston Scientific to Acquire Remaining 65% Stake in Cryterion Medical 118
Boston Scientific Acquires NxThera 119
Boston Scientific Acquires nVision Medical 120
Boston Scientific Acquires Securus Medical 121
Boston Scientific Acquires EMcision 122
Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede 123
Boston Scientific Acquires Apama Medical 124
Boston Scientific Acquires Symetis for USD435 Million 125
Boston Scientific Acquires 15% Stake in Neovasc for USD7 Million 126
Boston Scientific Acquires EndoChoice for USD214 Million in Tender Offer 127
Boston Scientific Acquires Cosman Medical 129
Boston Scientific Acquires 25% Stake in Frankenman Medical 130
Boston Scientific Acquires Xlumena for USD76 Million 131
Boston Scientific Enters into Option Agreement to Acquire MValve Technologies 132
Boston Scientific Acquires Remaining 72% Stake in IoGyn 133
Vanguard Acquires 6.7% Stake In Boston Scientific 134
Boston Scientific Completes Acquisition of Bard Electrophysiology From C. R. Bard For US$275 Million 135
Fidelity Acquires 10.5% Stake In Boston Scientific, Medical Device Company 137
EndoChoice Acquires RMS Endoskopie, Endoscopy Device Maker 138
Boston Scientific Completes Acquisition Of Vessix Vascular, Developer Of Catheter-Based Renal Denervation System, For Up to USD425 Million 139
Boston Scientific Completes Acquisition Of BridgePoint Medical, Cardiovascular Device Maker 141
Boston Scientific Completes Acquisition Of Rhythmia Medical, Cardiac Arrhythmia Device Maker, For Up To US$265 Million 142
Boston Scientific Completes Acquisition Of Cameron Health For Up To US$1.3 Billion 143
Covidien Completes Acquisition Of superDimension, Pulmonary Device Maker, For US$300 Million 145
Boston Scientific Corp – Key Competitors 147
Boston Scientific Corp – Key Employees 148
Boston Scientific Corp – Locations And Subsidiaries 150
Head Office 150
Other Locations & Subsidiaries 150
Recent Developments 155
Financial Announcements 155
Jul 25, 2018: Boston Scientific announces results for second quarter 2018 155
Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 156
Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 158
Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 160
Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 161
Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 163
Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 165
Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 166
Corporate Communications 168
Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 168
Legal and Regulatory 169
Jul 30, 2018: Nevro Announces Update on Patent Litigation 169
Jul 25, 2018: Nevro Announces Patent Litigation Update 170
Mar 28, 2018: Boston Scientific Prevails in U.K. Edwards Lifesciences Litigation 171
Government and Public Interest 172
Dec 22, 2017: Boston Scientific pacemakers and defibrillators 172
Nov 28, 2017: Boston Scientific Announces Update on LOTUS Edge Aortic Valve System 174
Mar 16, 2017: NICE Recommends Boston Scientific CRT-D Devices Powered By EnduraLife Battery Technology For Treatment Of Heart Failure 175
Mar 03, 2017: Boston Scientific Announces Six Finalists in 2nd Annual Connected Patient Challenge, Focused on Healthcare Data Analytics 176
Product News 177
May 16, 2018: Boston Scientific Announces Schedule of Presentations at EuroPCR 2018 177
Apr 16, 2018: Boston Scientific Prevails In European Patent Dispute With Edwards Lifesciences 178
Mar 23, 2018: Edwards Prevails In U.S. Patent Office Review That Finds Boston Scientific Transcatheter Valve Patent Claims Invalid 179
Jan 08, 2018: Spinal Cord Stimulation changes life of patient 180
Sep 13, 2017: New Unpublished Vascular Clinical Trial Results on drug-coated balloons Presented at VIVA 17 181
May 10, 2017: Boston Scientific to Present The LOTUS Valve System at EuroPCR 2017 182
May 09, 2017: Boston Scientific Receives U.S. FDA Approval For Resonate Family Of High-Voltage Devices 183
May 03, 2017: Boston Scientific Announces Scheduled Presentations at Heart Rhythm Society 2017 184
Feb 06, 2017: Boston scientific launches Resonate family of CRT-D devices in Europe 186
Other Significant Developments 187
Oct 01, 2018: Boston Scientific competition seeks innovative digital health concepts 187
Jun 21, 2018: SwedishAmerican First in Rockford to Offer ICD with Diagnostic Tool to Predict Heart Failure 188
Jan 29, 2018: Five devices for pediatrics get help in advancing to market 189
Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 190
Appendix 192
Methodology 192
About GlobalData 192
Contact Us 192
Disclaimer 192

List of Tables
Boston Scientific Corp, Medical Equipment, Key Facts, 2017 2
Boston Scientific Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Boston Scientific Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 10
Boston Scientific Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 11
Boston Scientific Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 12
Boston Scientific Corp, Deals By Market, 2012 to YTD 2018 13
Boston Scientific Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 14
Boston Scientific Acquires Tissue Processing Technology and Facility from Neovasc for USD68 Million 22
Boston Scientific Acquires Resectr Tissue Resection Device from Distal Access 23
Boston Scientific Acquires LumenR Tissue Retractor System from LumenR 24
Boston Scientific Acquires Interventional Radiology Business Of CeloNova Biosciences 25
Boston Scientific Acquires Men's Health and Prostate Health Businesses from American Medical Systems for USD1.65 Billion 26
Boston Scientific Acquires Vascular Catheter Business of Bayer for USD414 Million 28
Boston Scientific Acquires fiXate Tissue Band From Anulex Technologies 29
RenovoRx Raises USD7 Million in First Tranche of Venture Financing 30
Claret Medical Raises USD14.5 Million in Series C Financing 31
SetPoint Medical Raises USD30 Million in Series D Financing 32
Channel Medsystems Raises USD14.1 Million in Series C-1 Financing 34
Neuros Medical Raises USD20 Million in Series AA Financing 35
Amphora Medical Raises USD35.5 Million in Series B Financing 36
NxThera Raises Additional USD6 Million in Venture Financing 38
Claret Medical Raises USD11.2 Million Venture Financing 39
NeuroTronik Raises USD23 Million in Series B Financing 40
SetPoint Medical Raises Funds through Venture Financing 41
NxThera Raises Additional USD2.4 Million in Venture Financing 43
NxThera Raises USD12.2 Million in Venture Financing 44
Apama Medical Raises USD13 Million in Series C Financing 45
Securus Medical Raises USD10 Million in Series C Financing 46
nVision Medical Raises USD12 Million in Series B Financing 47
Apama Medical Raises USD9 Million in Venture Financing 48
nVision Medical Raises USD6.5 Million in Venture Financing 49
NxThera Raises USD40 Million Financing 50
TVA Medical Raises USD15 Million in Series C Financing 51
Setpoint Medical Raises Additional USD15 Million in Series C Venture Financing 52
Channel Medsystems Raises USD22 Million in Series C Financing Round 54
InterVene Raises USD5.9 Million in Series A Financing 55
EndoChoice Raises USD57 Million in Venture Financing 56
Apama Medical Raises USD11 Million in First Tranche of Series B Venture Financing Round 57
Claret Medical Raises up to USD18 Million in Series B Venture Financing 58
NxThera Raises Funds Through Extended Series C Financing 59
Amaranth Medical Raises Funds Through Venture Financing 60
Xlumena Raises US$25 Million In Series C Financing Round 61
Sensible Medical Raises US$20 Million In Venture Financing 62
Securus Medical Raises US$6.5 Million In Series B Financing 63
Xlumena Raises US$6 Million In Venture Financing 64
Apama Medical Raises US$3.2 Million In Series A-1 Financing Round 65
NXThera Raises US$18 Million In Series C Financing 66
Setpoint Medical Raises US$27 Million In Venture Financing 67
Claret Medical Raises US$3.6 Million In Venture Financing 68
Channel Medsystems Raises US$9.7 Million In Series B Financing 69
Baronova Raises US$27.3 Million In Series C Financing 70
EndoChoice Raises US$43 Million In Venture Financing 72
Xlumena Raises US$6 Million In Venture Financing 73
Securus Medical Group Secures USD0.25 Million in Venture Funding 74
Neuros Medical Raises US$3.5 Million In Second Round Of Financing 75
Symetis Enters Into Licensing Agreement With Endoluminal Sciences For Transcatheter Aortic Valve Implantation 76
BridgePoint Medical Enters Into Licensing Agreement With Covidien 77
Veniti Enters into Distribution Agreement with Boston Scientific 78
Boston Scientific Partners with Mayo Clinic 79
Boston Scientific Enters into Sales Cooperation Agreement with Preventice 80
Boston Scientific Enters into Agreement with Brainlab 81
Boston Scientific Enters into Distribution Agreement with C. R. Bard for Lutonix DCB 82
Boston Scientific Enters into Co-Development Agreement with Asahi Intecc 83
Boston Scientific Enters Into Distribution Agreement With Fukuda Denshi For Neuromodulation Devices 84
Boston Scientific Enters Into Agreement With Philips Healthcare 85
Vodafone Group Enters Into Co-Development Agreement With Boston Scientific For Health Monitoring System 86
Boston Scientific Extends Co-Marketing Agreement With Lumenis For Holmium Laser Fibers 87
EndoChoice And Peer Medical To Merge 88
Novartis Enters into Licensing Agreement with Boston Scientific for Everolimus 89
Symetis Withdraws French Public Offering of Shares 90
Corindus Vascular Robotics Raises USD45 Million in Private Placement of Shares 91
VENITI Raises USD25 Million in Series D Equity Financing 93
MValve Technologies Raises Additional Funds through Private Placement of Shares 94
Symetis to Raise USD109.1 Million in IPO 95
Preventice Raises Funds through Private Placement of Shares 96
EndoChoice Raises USD106 Million in IPO 97
Iowa Approach Raises Funds through Private Placement of Shares 99
Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028 100
Boston Scientific Raises USD600 Million in Public Offering of 2.850% Notes Due 2020 102
Boston Scientific Raises USD750 Million in Public Offering of 3.850% Notes Due 2025 104
Boston Scientific Raises USD500 Million in Public Offering of 3.375% Notes Due 2022 106
Boston Scientific Completes Public Offering Of Notes Due 2018 For US$600 Million 108
Boston Scientific Completes Public Offering Of Notes Due 2023 For US$450 Million 110
Boston Scientific Acquires Men's Health and Prostate Health Businesses from American Medical Systems for USD1.65 Billion 112
Medifocus Completes Acquisition Of Prolieve Business From Boston Scientific For Up To USD5 Million 114
Boston Scientific to Acquire Augmenix for USD600 Million 115
Boston Scientific to Acquire VENITI 116
Boston Scientific Acquires Claret Medical for up to USD270 Million 117
Boston Scientific to Acquire Remaining 65% Stake in Cryterion Medical 118
Boston Scientific Acquires NxThera 119
Boston Scientific Acquires nVision Medical 120
Boston Scientific Acquires Securus Medical 121
Boston Scientific Acquires EMcision 122
Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede 123
Boston Scientific Acquires Apama Medical 124
Boston Scientific Acquires Symetis for USD435 Million 125
Boston Scientific Acquires 15% Stake in Neovasc for USD7 Million 126
Boston Scientific Acquires EndoChoice for USD214 Million in Tender Offer 127
Boston Scientific Acquires Cosman Medical 129
Boston Scientific Acquires 25% Stake in Frankenman Medical 130
Boston Scientific Acquires Xlumena for USD76 Million 131
Boston Scientific Enters into Option Agreement to Acquire MValve Technologies 132
Boston Scientific Acquires Remaining 72% Stake in IoGyn 133
Vanguard Acquires 6.7% Stake In Boston Scientific 134
Boston Scientific Completes Acquisition of Bard Electrophysiology From C. R. Bard For US$275 Million 135
Fidelity Acquires 10.5% Stake In Boston Scientific, Medical Device Company 137
EndoChoice Acquires RMS Endoskopie, Endoscopy Device Maker 138
Boston Scientific Completes Acquisition Of Vessix Vascular, Developer Of Catheter-Based Renal Denervation System, For Up to USD425 Million 139
Boston Scientific Completes Acquisition Of BridgePoint Medical, Cardiovascular Device Maker 141
Boston Scientific Completes Acquisition Of Rhythmia Medical, Cardiac Arrhythmia Device Maker, For Up To US$265 Million 142
Boston Scientific Completes Acquisition Of Cameron Health For Up To US$1.3 Billion 143
Covidien Completes Acquisition Of superDimension, Pulmonary Device Maker, For US$300 Million 145
Boston Scientific Corp, Key Competitors 147
Boston Scientific Corp, Key Employees 148
Boston Scientific Corp, Other Locations 150
Boston Scientific Corp, Subsidiaries 151

List of Figures
Boston Scientific Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Boston Scientific Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Boston Scientific Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Boston Scientific Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Boston Scientific Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 10
Boston Scientific Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 11
Boston Scientific Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 12
Boston Scientific Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 13

★海外企業調査レポート[Boston Scientific Corp (BSX)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • TE Connectivity Ltd (TEL)：企業の財務・戦略的SWOT分析
    TE Connectivity Ltd (TEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Twenty-First Century Fox, Inc.：企業の戦略・SWOT・財務情報
    Twenty-First Century Fox, Inc. - Strategy, SWOT and Corporate Finance Report Summary Twenty-First Century Fox, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Nissan Motor Co., Ltd.：企業の戦略・SWOT・財務情報
    Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • ENCE Energia Y Celulosa SA (ENC)：企業の財務・戦略的SWOT分析
    ENCE Energia Y Celulosa SA (ENC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Western & Southern Financial Group, Inc.：戦略・SWOT・企業財務分析
    Western & Southern Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Western & Southern Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Trevena Inc (TRVN)-製薬・医療分野：企業M&A・提携分析
    Summary Trevena Inc (Trevena) is a biopharmaceutical company that discovers and develops G-protein coupled receptor targeted medicines. The company’s products include RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination with …
  • Duff & Phelps Corporation：企業のM&A・事業提携・投資動向
    Duff & Phelps Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Duff & Phelps Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Chevron Corp (CVX)：電力：M&Aディール及び事業提携情報
    Summary Chevron Corp (Chevron) is an integrated oil and gas company. It operates in the oil and gas value chain from exploration and production, storage and pipeline transportation to refining, marketing and distribution of oil and gas products. Chevron explores for, produces and transports crude oi …
  • Saint-Gobain Ltd：企業の戦略的SWOT分析
    Saint-Gobain Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Millennium Pharmaceuticals Inc-製薬・医療分野：企業M&A・提携分析
    Summary Millennium Pharmaceuticals Inc (Millennium), a subsidiary of Takeda Pharmaceutical Company Ltd is a biopharmaceutical company that undertakes research, development, and commercialization of drugs for treating cancer. The company’s product Velcade is used for the treatment of multiple myeloma …
  • DiaGenic ASA (NEL)：医療機器：M&Aディール及び事業提携情報
    Summary DiaGenic ASA (DiaGenic) is a medical device company that develops and markets blood based biomarkers for early detection of Alzheimer’s disease. The company offers MCItect, ADtect and AMYtect products. Its ADtect is a blood test that helps distinguish mild to moderate range AD from the absen …
  • Instrumentation Laboratory Co：企業の戦略的SWOT分析
    Instrumentation Laboratory Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • TETRA Technologies Inc (TTI)：企業の財務・戦略的SWOT分析
    Summary TETRA Technologies Inc (TETRA) is an oil and gas company that offers completion fluids and associated products and services. It offers compression services, fluid, filtration and tools services, offshore services, production testing, rig cooling services, technology center and water manageme …
  • Sohu.com Inc. (SOHU)：企業の財務・戦略的SWOT分析
    Sohu.com Inc. (SOHU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Maroc Telecom SA (IAM)：企業の財務・戦略的SWOT分析
    Maroc Telecom SA (IAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • BE Semiconductor Industries N.V. (BESI)：企業の財務・戦略的SWOT分析
    BE Semiconductor Industries N.V. (BESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • JA Solar Holdings Co Ltd (JASO)：企業の財務・戦略的SWOT分析
    JA Solar Holdings Co Ltd (JASO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • L.L. Bean, Inc.：企業の戦略・SWOT・財務情報
    L.L. Bean, Inc. - Strategy, SWOT and Corporate Finance Report Summary L.L. Bean, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Tongaat Hulett Ltd (TON)：企業の財務・戦略的SWOT分析
    Tongaat Hulett Ltd (TON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • QCR Holdings, Inc.：企業のM&A・事業提携・投資動向
    QCR Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's QCR Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆